Innovations in 3D Printing of Pharmaceutical Products - Genetic Technology TOE

USD 250.00

* Required Fields

USD 250.00


Be the first to review this product

This edition of the Genetic Technology TOE depicts innovations in 3D printing of pharmaceutical products. Different technology platforms and diverse applications are illustrated. The corresponding patent scenario is depicted, along with the industry interactions.The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through technology transfer, joint ventures, and acquisitions. The complete gamut of genetic technology applications is covered including the latest developments in omics technologies; genetic, cellular, and alternative therapies; sequencing technologies; and

Table of Contents

Innovations in 3D Printing of Pharmaceutical Products - Genetic Technology TOETechnology Profiles3D Printing and Hot Meld Extrusion for Developing Drug CompoundsZipDose Technology Platform Results in Highly Soluble Epileptic Drug Laboratory Mouse Gives Birth to Litter of Mice Using 3D Bio-printed Ovary 3D Bio-printed Tissue Samples Key for Drug Discovery and Therapeutics Applications Analyst InsightsAnalyst Insights – Impact of 3D Printing on PharmaAppendixPatent ScenarioIndustry Interactions

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.